Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-02-28

FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for Claritin Allergy (loratadine) by Bayer HealthCare LLC, indicating a labeling change or addition. The action concerns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claritin Allergy (Loratadine)

Snippet

SUPPL AP for CLARITIN ALLERGY (LORATADINE)